Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5290046012 | Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5290047015 | Balsam of Peru 18 mg/g and bismuth oxide 21.4 mg/g and zinc oxide 107.5 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Balsam of Peru | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Balsam of Peru | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Bismuth oxide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Bismuth oxide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR